Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Institut Produits Synthése (IPSEN) AB
AB
Active
Org 5567013106
Färögatan 33, 164 51
Kista
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2006
68 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Institut Produits Synthése (IPSEN) AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
EM
Elina Marita Öberg
Chief Auditor
Chief Auditor
2025
Former (1)
MU
Magnus Urmas Prööm
Chief Auditor
Chief Auditor
2021 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
JD
Julien Darrigade
Board of Directors
2021
JD
Julien Dagher
Chairman
2025
RG
Rafael Giglio
Board of Directors
2025
Former (5)
AA
Abla Alami ép. Abrial
Board of Directors
2022 – 2025
AE
Alexandre Ernest Visciglio
Board of Directors
2021 – 2022
DJ
Dominique Jeannine Suzanne Bery
Chairman
2022 – 2025
SS
Sunjeet Sawhney
Chairman
2021 – 2022
DD
Daoud Daya
Chairman
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Institut Produits Synthése (IPSEN) AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
